Identifying and Controlling CPPs and CMAs.
| Published in: | BioPharm International Vol. 31; no. 3; pp. 38 - 42 |
|---|---|
| Main Author: | |
| Format: | Journal Article |
| Published: |
MJH Life Sciences
Mar2018
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128480952&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 128480952 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Mar2018 vid: 31 iid: 3 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 128480952 128480952 ppf: 38 ppct: 4 formats: fmt: @attributes: type: P tig: atl: Identifying and Controlling CPPs and CMAs. aug: au: Little, Thomas A. affil: President/CEO of Thomas A. Little Consulting, BioAssay Sciences, 12401 N Wildflower Lane Highland, UT 84003, 1.925.285.1847 sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|